Earnings
AVIR
25.11
-1.65%
-0.42
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
850.12M
--
--
5.82M
--
--
0.00
--
--
--
7.54M
--
863.48M
48.00K
--
--
--
--
--
--
107.00K
155.00K
863.63M
--
60.00K
0.00
--
--
--
--
--
14.37M
--
--
--
301.37M
315.80M
0.00
--
--
--
36.00K
36.00K
315.83M
82.00K
612.88M
-65.16M
--
--
--
547.80M
547.80M
863.63M
FY 2019-12-31
21.66M
--
--
--
--
--
0.00
--
--
--
249.00K
--
21.91M
41.00K
--
--
--
--
--
--
122.00K
163.00K
22.07M
--
548.00K
0.00
--
--
--
--
--
1.89M
--
--
--
1.89M
2.44M
0.00
--
--
--
95.00K
95.00K
2.53M
10.00K
4.63M
-54.21M
--
--
--
19.54M
19.54M
22.07M
FY 2018-12-31
34.49M
--
--
--
--
--
0.00
--
--
--
206.00K
--
34.70M
56.00K
--
--
--
--
--
--
107.00K
163.00K
34.86M
--
391.00K
0.00
--
--
--
--
--
1.37M
--
--
--
1.37M
1.76M
0.00
--
--
--
148.00K
148.00K
1.91M
10.00K
4.01M
-40.18M
--
--
--
32.95M
32.95M
34.86M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out AVIR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Atea Pharmaceuticals, Inc. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.